KRAS and breast cancer: However, PLK1 overexpression has also been shown to result in segregational and cytokinetic defects, thus generating polyploid cells; this prevents the development of KRAS- and HER2-induced mammary tumors in vivo, suggesting the contribution of intracellular PLK1 expression levels to carcinogenesis could be both dose- and context-dependent [112].